共 118 条
[1]
Esquivel J(2007)Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology Ann Surg Oncol 14 128-133
[2]
Sticca R(2010)Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients Cancer 116 5608-5618
[3]
Sugarbaker P(2008)8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 2426-2432
[4]
Levine E(2016)Surgical technology and pharmacology of hyperthermic perioperative chemotherapy J Gastrointest Oncol 7 29-44
[5]
Yan TD(2016)Laparoscopic HIPEC: a bridge between open and closed-techniques J Minim Access Surg 12 86-89
[6]
Alexander R(2012)Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature Ann Surg Oncol 19 2946-2950
[7]
Baratti D(2015)Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes J Minim Invasive Gynecol 22 428-432
[8]
Bartlett D(2011)Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience Ann Surg 253 764-768
[9]
Barone R(2017)Water lavage as an adjunct to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) Am J Surg 214 462-467
[10]
Barrios P(2018)A multicenter randomized trial to evaluate hematologic toxicities after hyperthermic intraperitoneal chemotherapy with oxaliplatin or mitomycin in patients with appendiceal tumors J Am Coll Surg 226 434-443